Showing 261-270 of 2875 results for "".
The No Surprises Act and Aesthetic Patients
https://modernaesthetics.com/ma-podcasts/the-modern-aesthetics-podcast/the-no-surprises-act-and-aesthetic-patients/33932/In December 2020, Congress passed the No Surprises Act as part of a larger COVID-19 relief package. This Act reduces the occurrence of surprise bills after a medical service or procedure, and it affects aesthetics a lot more than most people realize. San Franciso plastic surgeon Jonathan Kaplan,MATV News: Endo Pulls Qwo from Market; Merz Aesthetics Adds SaltFacial; Current Trends in Aesthetic Medicine
https://modernaesthetics.com/series/matv-news/matv-news-endo-pulls-qwo-from-market-merz-aesthetics-adds-saltfacial-current-trends-in-aesthetic-medicine/33713/Endo International is ceasing the production and sale of Endo Aesthetics' injectable cellulite treatment Qwo; Merz Aesthetics is adding the SaltFacial to its portfolio through an extended commercial agreement with SaltMED; and New York City dermatologist Dr. Robert Finney discusses trends in aesthetAAFPRS Mission Trip to Ukraine
https://modernaesthetics.com/ma-podcasts/the-modern-aesthetics-podcast/aafprs-mission-trip-to-ukraine/33931/Founded in 1992, FACE TO FACE is a humanitarian and educational surgical exchange program sponsored by the Educational and Research Foundation for the American Academy of Facial Plastic and Reconstructive Surgery. Both in the United States and abroad, AAFPRS surgeons and other medical professionaMATV News Extra: A Q&A with Dr. Theda Kontis, AAFPRS President
https://modernaesthetics.com/series/matv-news/matv-news-extra-a-qa-with-dr-theda-kontis-aafprs-president/33711/Theda C. Kontis, MD, FACS the second woman to serves as American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) president, recently sat down with MATV News to discuss her new role and her goals, including continuing to move the academy and foundation forward by further increasing tranMATV News: AAFPRS President Dr. Theda Kontis Takes Office; Aesthetic Society and ASERF Unveil BII Study Results; The Role of AI in Skincare
https://modernaesthetics.com/series/matv-news/matv-news-aafprs-president-dr-theda-kontis-takes-office-aesthetic-society-and-aserf-unveil-bii-study-results-the-role-of-ai-in-skincare/33710/New AAFPRS President Dr. Theda Kontis shares goals for her term, the Aesthetic Society and ASERF unveil findings from the Biospecimen study on breast implant illness; and a new report from Perfect Corp. looks at the growing role artificial intelligence and digital skin analysis is playing in risingMATV News: DREAM Initiative’s Forces of Beauty Report; AAFPRS Medical Mission Trip to Ukraine; Galderma’s Investigational Neurotoxin Gets High Marks
https://modernaesthetics.com/series/matv-news/matv-news-dream-initiatives-forces-of-beauty-report-aafprs-medical-mission-trip-to-ukraine-galdermas-investigational-neurotoxin-gets-high-marks/33706/Allergan Aesthetics and skinbetter science have released a new report from their DREAM Initiative. The Forces of Beauty report provides a new understanding of what inclusive and representative beauty looks like today. Plastic surgeon Kelly Bolden, MD discusses the importance of the findings. AmericaMATV News: Revance’s Daxxify Approved; ASPS Data Show Cosmetic Surgery Booming; DREAM Initiative Supports Residency Curriculum for Advancing Racial Equity
https://modernaesthetics.com/series/matv-news/matv-news-revances-daxxify-approved-asps-data-show-cosmetic-surgery-booming-dream-initiative-supports-residency-curriculum-for-advancing-racial-equity/33703/Revance Therapeutics’ Daxxify (daxibotulinumtoxinA-lanm) wins FDA approval for the temporary improvement of moderate to severe glabellar lines in adults. Clinical trial investigator Jeffrey Dover, MD discusses Daxxify’s unique Peptide Exchange Technology (PXT) and long-lasting effects. New data fromMATV News: Juvéderm Volux XC Approved; Joe Jonas and Xeomin Partner; Breast Implants Recipients Not Following Screening Guidelines
https://modernaesthetics.com/series/matv-news/matv-news-juvederm-volux-xc-approved-joe-jonas-and-xeomin-partner-breast-implants-recipients-not-following-screening-guidelines/33701/Allergan Aesthetics wins FDA approval for Juvéderm Volux XC for the improvement of jawline definition in adults with moderate to severe loss of jawline definition; Pop icon Joe Jonas is the new brand partner for Merz Aesthetics’ Xeomin; and a new study finds silicone breast implant recipients may noMATV News: Promising Data for Galderma's RelabotulinumtoxinA; FDA Approves Sientra's New Breast Implant; Allergan Aesthetics Shares Global Trends Report
https://modernaesthetics.com/series/matv-news/matv-news-promising-data-for-galdermas-relabotulinumtoxina-fda-approves-sientras-new-breast-implant-allergan-aesthetics-shares-global-trends-report/33697/Galderma's investigational RelabotulinumtoxinA, a novel liquid formulation botulinum toxin A, improves glabellar and lateral canthal lines with a rapid onset of action and a long duration up to six months, according to top-line Phase 3 data; and Sientra wins FDA approval for its Low Plus Profile ProMATV News: Dr. Jennifer Walden is First Female President of The Aesthetic Society; Plastic Surgeon Residents Face Childcare Issues; ASLMS President Outlines Goals
https://modernaesthetics.com/series/matv-news/matv-news-dr-jennifer-walden-is-first-female-president-of-the-aesthetic-society-plastic-surgeon-residents-face-childcare-issues-aslms-president-outlines-goals/33685/Jennifer Walden, MD discusses her role and goals as the first female president of the Aesthetic Society; a new survey study finds plastic surgeon residents, especially women, face barriers accessing affordable childcare; and Paul Friedman, MD shares plans for his ASLMS presidency, including creating